US 10035823
Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions
granted A61KA61K2039/545A61K38/00
Quick answer
US patent 10035823 (Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions) held by The Regents of the University of California expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/545, A61K38/00, A61K39/0005, A61K39/0008